These findings highlight ACSL1 and ACSL4 as promising therapeutic targets for diabetes, with their mechanisms closely related to lipid metabolism, lipid peroxidation, inflammation, and ferroptosis. The gene discussed is ACSL1; the disease is diabetes mellitus.